System, device and method for dynamic glucose curve response to physiological parameters

Through the multi-stage glucose response mode determination and dynamic adjustment system of smartphones and sensor networks, the problem of uncontrolled glucose fluctuations in daily activities in diabetic patients is solved, and precise monitoring and personalized management of glucose levels are achieved.

CN113349766BActive Publication Date: 2024-11-22ABBOTT DIABETES CARE INC
View PDF 49 Cites 0 Cited by

Patent Information

Application Number
CN202110572460.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2016-03-11
Filing Date
2016-07-08
Publication Date
2024-11-22
Estimated Expiration
2036-07-08

AI Technical Summary

Technical Problem

The prior art is difficult to effectively monitor and control the glucose levels of diabetic patients, especially in daily activities such as exercise, medication, meals, etc., which leads to uncontrollable glucose fluctuations and large errors in drug dosage measurement.

Method used

A system for multi-stage glucose response mode determination and dynamic adjustment is developed, using smartphones and sensor networks to provide personalized treatment recommendations through data analysis and dynamic updates, combining drug pumps or syringes to monitor and adjust glucose levels in real time.

Benefits of technology

Accurate monitoring and dynamic adjustment of glucose levels in diabetic patients is achieved, errors in drug dosage measurement are reduced, and personalized health management advice is provided to help patients maintain glucose stability in daily activities.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113349766B_ABST
    Figure CN113349766B_ABST
Patent Text Reader

Abstract

The present invention relates to a system, device and method for dynamic glucose curve response to physiological parameters. Methods, devices and systems for providing consistent and reliable glucose response information to physiological changes and / or activities are provided to improve blood sugar control and health management.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of Chinese Patent Application No. 201680052614.1, filed on July 8, 2016, entitled “System, Device and Method for Dynamic Glucose Curve Response to Physiological Parameters”. Technical Field

[0002] Related Applications

[0003] This application is related to U.S. Provisional Application No. 62 / 307,346 filed on March 11, 2016, U.S. Provisional Application No. 62 / 191,218 filed on July 10, 2015, and U.S. Provisional Application No. 62 / 307,344 filed on March 11, 2016, entitled "Systems, Devices, and Methods For Mealinformation Collection, Meal Assessment, and Analyte Data Correlation", the disclosures of each of which are incorporated herein by reference for all purposes.

[0004] Incorporation by reference

[0005] The patents, applications and / or publications described herein, including the following, are incorporated herein by reference for all purposes: U.S. Patent Nos. 4,545,382; 4,711,245; 5,262,035; 5,262,305; 5,264,104; 5,320,715; 5,356,786; 5,509,410; 5,543,326; 5,593,852; 5,601,435; 5,628,890; 5,820,551; 5,822,715; 5,899,855; 5,918,603; 6,071,391; 6,103,033; 6,120,676; 6 ,121,009;6,134,461;6,143,164;6,144,837;6,161,095;6,175,752;6,270,455;6,284,478;6,299,757;6,338,790;6,377,894;6,461,496;6,5 03,381; 6,514,460; 6,514,718; 6,540,891; 6,560,471; 6,579,690; 6,591,125; 6,592,745; 6,600,997; 6,605,200; 6,605,201; 6,616,819; 6,618, 934; 6,650,471; 6,654,625; 6,676,816; 6,730,200; 6,736,957; 6,746,582; 6,749,740; 6,764,581; 6,773,671; 6,881,551; 6,893,545; 6,932,892; 6,932,894; 6,942,518; 7,041,468; 7,167,818; and 7,299,082; U.S. Published Application No. 2004 / 0186365, now U.S. Patent No. 7,811,231; 2005 / 0182306, now U.S. Patent No. 8,771,183; 200 6 / 0025662, now U.S. Patent No. 7,740,581; 2006 / 0091006; 2007 / 0056858, now U.S. Patent No. 8,298,389; 2007 / 0068807, now U.S. Patent No. 7,846,311; 2007 / 0095661; 2007 / 0108048, now U.S. Patent No. 7,918,975; 2007 / 0199818, now U.S. Patent No. 7,811,430; 2007 / 0227911, now U.S. Patent No. 7,887,682; 2007 / 0233013; 2008 / 0066305, now U.S. Patent No. 7,895,740;2008 / 0081977, now U.S. Patent No. 7,618,369; 2008 / 0102441, now U.S. Patent No. 7,822,557; 2008 / 0148873, now U.S. Patent No. 7,802,467; 2008 / 0161666; 2008 / 0267823; and 2009 / 0054748, now U.S. Patent No. 7,885,698; U.S. Patent Application Serial Nos. 11 / 461,725, now U.S. Patent No. 7,866,026; 12 / 131,012; 12 / 393,921, 12 / 242,82 3, now U.S. Patent No. 8,219,173; 12 / 363,712, now U.S. Patent No. 8,346,335; 12 / 495,709; 12 / 698,124; 12 / 698,129; 12 / 714,439; 12 / 794,721, now U.S. Patent No. 8,595,607; and 12 / 842,013 and U.S. Provisional Application Nos. 61 / 238,646, 61 / 246,825, 61 / 247,516, 61 / 249,535, 61 / 317,243, 61 / 345,562 and 61 / 361,374. ; Background Art

[0006] Detecting and / or monitoring glucose levels or other analytes (e.g., lactate, oxygen, A1C, etc.) in certain individuals is critical to their health. For example, monitoring glucose levels is particularly important for individuals with diabetes and those with conditions that indicate the onset of diabetes. Diabetic patients typically monitor glucose levels to determine whether their glucose levels are maintained within a clinically safe range, and may also use this information to determine if and / or when insulin is needed to lower the glucose level in their body or when additional glucose is needed to increase the glucose level in their body.

[0007] With the development of glucose monitoring devices and systems that provide real-time glucose level information in a convenient and painless manner, there is a continuing desire to integrate such monitoring devices and systems into daily life and activities to improve glucose control. More specifically, it is highly desirable to determine the impact of daily activities such as exercise, medication, meals, etc. on glucose level fluctuations and provide actionable, personalized health-related information to closely control glucose changes. In addition, it is highly desirable to provide accurate assessment of the accuracy of drug dosage determination by taking into account parameters that affect drug therapy in daily activities including exercise and meals, while reducing errors in such determinations. Summary of the invention

[0008] Embodiments of the present disclosure include multi-stage glucose response pattern determination and dynamic adjustment or modification to personalize the glucose response of specific activities and external parameters related to specific patients or users. In certain embodiments, the analysis module is provided as a software application ("App") that can be executed by any processor-controlled device, and specifically, a smart phone with communication capabilities for receiving, analyzing, transferring, transmitting, displaying or outputting actionable information, such as a treatment recommendation including a glucose response pattern based on the determination. In certain embodiments, the glucose response pattern determined by any other external parameter specific to a specific activity or activity combination, dietary intake, drug intake, or a user or patient's daily activity is intelligently and dynamically adjusted on a continuous real-time basis (when receiving and analyzing additional activity-specific or external parameter-specific data through the App).

[0009] Embodiments of the present disclosure include an overall network of sensor-based devices that communicate with a smartphone configured to execute an App, and optionally a data communication network with one or more back-end server terminals that provide a network cloud configuration, which is configured to perform the functions of the App to perform analysis, such as when performing direct data communication with the sensor-based device, and provide the analysis results to the smartphone, or is configured to operate in a more passive manner, such as performing data backup functions or data repository functions (for the smartphone and / or sensor-based device). Moreover, optionally included in the overall network are one or more drug devices, such as an insulin pump or insulin injector pen, which are configured to receive analysis data from the smartphone, from one or more back-end server terminals, or directly from the sensor-based device.

[0010] Embodiments of the present disclosure include a data collection phase during which user or patient specific information is collected, for example, from one or more sensor-based devices, by manual user input or from a drug delivery device over a predetermined time period. When a sufficient amount of information about a patient or user is determined, as it relates to glucose response and glucose change (e.g., a minimum of 5 days, 6 days, 1 week, 10 days, 14 days, or any one or more combinations of days or portions of days), an App executed on a smartphone in certain embodiments may prompt the user or patient that a specific glucose response pattern has been determined or identified and that user input for response analysis is ready. To achieve this, in certain embodiments, the App analyzes data or information from sensor-based devices and other received user or patient specific parameters, and classifies the received data as part of the data analysis to determine the glucose response pattern, after which the response pattern is continuously and dynamically updated using additional real-time information received from one or more sensor-based devices or other user or patient specific parameters. In this manner, in certain embodiments, when a user inputs an activity or parameters in which the user desires to engage (e.g., a 90 minute run including an incline of approximately 1000 feet, or a number of steps taken during an established time period such as 12 hours, 18 hours, 24 hours, or other suitable time period), an App using dynamic glucose response pattern recognition capabilities is configured to notify the user or patient that the activity will result in a specific glucose response (e.g., a decrease in glucose levels (post-activity) of approximately 25 mg / dL).

[0011] Furthermore, in some embodiments, in addition to the physical activity driven analysis performed, the App may also be configured to provide recommendations, such as, for example, providing a list of food types and amounts to be consumed at specific times before engaging in an activity and / or within a fixed time after the activity, so as to minimize glucose fluctuations beyond a predetermined range over a set time period spanning before, during, and after the activity. In some embodiments, the App is configured to perform a similar analysis as described above using recommendations, wherein instead of the physical activity to be performed, the analysis involves the amount of medication, food, beverage, or one or more combinations thereof to be consumed. In this way, in some embodiments, a user or patient can take action before consuming food and / or beverages or administering medication.

[0012] These and other features, objects and advantages of the present disclosure will become apparent to those skilled in the art after reading the details of the present disclosure, as more fully described below. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 is a holistic glucose response data analysis system according to one embodiment of the present disclosure;

[0014] Figure 2A According to one embodiment of the present disclosure Figure 1 Block diagram of the analysis module;

[0015] Figure 2B shows a combination according to one embodiment of the present disclosure Figure 1 Information flow of analytical modules (performing data classification, pattern recognition and dynamic updating);

[0016] Figure 3 is a data input interface 111 ( Figure 2A )'s exemplary screen shot;

[0017] Figure 4 is a flow chart showing a routine for determining the effect of daytime activity on overnight glucose levels according to one embodiment of the present disclosure;

[0018] Figure 5 is a flow chart showing another routine for determining the effect of daytime activity on overnight glucose levels according to one embodiment of the present disclosure;

[0019] Figure 6 is a flow chart showing glucose response pattern recognition and characterization of specific activities based on absolute overnight glucose levels according to one embodiment of the present disclosure;

[0020] Figure 7 is a flow chart showing the recognition and characterization of glucose response patterns for specific activities based on diurnal glucose level variations according to one embodiment of the present disclosure;

[0021] Figure 8 is a flow chart showing the recognition and characterization of glucose response patterns for specific activities based on the ratio of diurnal glucose levels according to one embodiment of the present disclosure;

[0022] Fig. 9 shows a process flow for training and notification according to one embodiment of the present disclosure;

[0023] Fig.10 shows a process flow for training and notification according to another embodiment of the present disclosure;

[0024] Fig.11 The linear fit analysis based on the data set of the assays shown in Table 2 is shown on days with activity relative to the corresponding R values;

[0025] Fig.12 Linear fit analysis based on delta median glucose (Gδ(X days)) versus activity level (number of steps) is shown for the data set based on the assays shown in Table 2 ;

[0026] Fig.13 Shows R values ​​plotted against days with activity based on the data set of assays shown in Table 4;

[0027] Fig.14 shows the data set based on the assays shown in Table 4, with delta median glucose (Gδ(X days)) plotted against the activity metric (Act(X days)) and a linear fit analysis performed; and

[0028] Fig.15 A linear fit analysis based on the data set of assays shown in Table 6 is shown by plotting the median glucose ratio (Gactd2nr(X days)) against the activity measure (Act) for days with significant activity. DETAILED DESCRIPTION

[0029] Before describing the present disclosure in detail, it should be understood that the present disclosure is not limited to the particular embodiments described, and therefore may of course vary. It should also be understood that the terminology used herein is only for the purpose of describing particular embodiments, and is not intended to be limiting, as the scope of the present disclosure will be limited only by the appended claims.

[0030] Where a numerical range is provided, it is understood that each intervening value to the tenth of the unit of the lower limit, and any other specified or intervening value within the range, between the upper and lower limits of the range is included in the disclosure unless the context clearly indicates otherwise. The upper and lower limits of these smaller ranges may be independently included in the smaller ranges, and any explicitly excluded limits within the specified ranges are also included in the disclosure. Where a specified range includes one or both limits, ranges excluding either or both of those included limits are also included in the disclosure.

[0031] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the present disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and / or materials associated with the cited publications.

[0032] It must be noted that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.

[0033] The publications discussed herein are provided only for their disclosure prior to the filing date of the present application. Anything herein should not be construed as admitting that the present disclosure has no right to precede such disclosure due to prior disclosure. In addition, the publication date provided may be different from the actual publication date that needs to be independently confirmed.

[0034] As will be apparent to those skilled in the art after reading this disclosure, each individual embodiment described and illustrated herein has discrete components and features that may be readily separated or combined with the features of any one of the other multiple embodiments without departing from the scope or spirit of the disclosure.

[0035] The drawings shown herein are not necessarily drawn to scale, with some components and features exaggerated for the sake of clarity.

[0036] Figure 1 1 is an overall glucose response data analysis system according to one embodiment of the present disclosure. Referring to the figure, in certain embodiments, the glucose response data analysis system 100 includes a mobile phone 110, which includes a user interface 110A and an analysis module 110B programmed as an App (e.g., installed as an executable file downloaded from a data network 140 of a server 150) in the mobile phone 110. As discussed in further detail below, in certain embodiments, data conditioning, analysis, and dynamic glucose response pattern recognition and / or updated glucose response pattern recognition are performed as one or more executable routines (routines) by the App.

[0037] Return to reference Figure 1 , also shown are activity monitor 130A, heart rate monitor 130B, and glucose monitor 130C, each in data communication with mobile phone 110, or alternatively or in addition to each in data communication with server 150 via data network 140. In this manner, in certain embodiments, each activity monitor 130A, heart rate monitor 130B, glucose monitor 130C is programmed to communicate monitored information to server 150 for storage and / or analysis, or to mobile phone 110 for storage, analysis, and subsequent communication of either or both raw data received from each activity monitor 130A, heart rate monitor 130B, glucose monitor 130C, and / or to communicate processed data or information from each activity monitor 130A, heart rate monitor 130B, glucose monitor 130C to server 150 via a data network for storage and / or further analysis.

[0038] Also refer to Figure 1Also shown in the glucose response data analysis system 100 is a drug delivery device 120, which is in data communication with the mobile phone 110, the server 150, or one or more of the activity monitor 130A, the heart rate monitor 130B, and the glucose monitor 130C via the data network 140. Although not shown, in certain embodiments, the operation of the routines and functions of the App can be implemented in the drug delivery device 120, wherein the drug delivery device 120 directly receives data or information from one or more of the activity monitor 130A, the heart rate monitor 130B, and the glucose monitor 130C, and performs glucose response pattern recognition and analysis, and modifies the drug delivery curve (e.g., basal insulin delivery rate, determination of bolus insulin dose) based on the determined glucose response pattern from the monitoring data (e.g., physiological monitoring condition, and / or consumption of food and / or beverage, and medication intake) (taking into account the proposed physical activity and / or food or beverage consumption).

[0039] In some embodiments, the mobile phone 110 includes one or more activity monitors 130A, heart rate monitors 130B, glucose monitors 130C integrated into the mobile phone 110. For example, in some embodiments, the mobile phone 110 includes an accelerometer and / or gyroscope capable of monitoring the movement of the user of the mobile phone 110, such as keeping track or recording the number of steps taken, physical activity participated in (when the mobile phone 110 is on or near the body, such as using an armband), such as the number of steps taken, running, jogging, sprinting, each with a degree or level of intensity. In some embodiments, the mobile phone 110 is configured as a wristwatch configuration, in which case the mobile phone 110 also includes a heart rate monitor in addition to the accelerometer or gyroscope. In some embodiments where the mobile phone 110 is configured as a wristwatch, the mobile phone 110 incorporates a glucose sensor (in vivo, dermal, transdermal or optical) so that the real-time monitoring function of glucose levels is incorporated into the mobile phone 110.

[0040] Referring again to the glucose responsiveness data analysis system 100, in certain embodiments, a hub device (not shown) may be incorporated into the glucose responsiveness data analysis system 100 that is configured to communicate with one or more of the activity monitor 130A, the heart rate monitor 130B, the glucose monitor 130C for data reception, storage, and subsequent communication with other devices in the glucose responsiveness data analysis system 100 via the data network 140, or directly communicate with other devices in the glucose responsiveness data analysis system 100 (e.g., the mobile phone 110 and / or the drug delivery device 120). In certain embodiments, the hub device is configured as a passthrough relay device or adapter that collects information from one or more of the activity monitor 130A, the heart rate monitor 130B, the glucose monitor 130C, and transmits or sends the collected data to the server 150, the mobile phone 110, and / or the drug delivery device 120 in real time or after a specific period of data collection. In certain embodiments, the hub device is physically embodied as a small, discrete key fob type or dongle type device that the user or patient holds close to the body and communicates directly with the activity monitor 130A, heart rate monitor 130B, and glucose monitor 130C worn on the body. In addition, although three activity monitors 130A, heart rate monitor 130B, and glucose monitor 130C are shown in the glucose response data analysis system 100, it is within the scope of the present disclosure to provide additional sensors to monitor other or related parameters of the user. For example, parameters for monitoring or measuring by one or more sensors include, but are not limited to, sweat levels, temperature levels, heart rate variability (HRV), neural activity, eye movements, speech, and the like. In certain embodiments of the glucose response data analysis system 100, each one or more of these monitored parameters are used as input parameters of the analysis module 110B of the mobile phone 110, as discussed in further detail below.

[0041] Figure 2A According to one embodiment of the present disclosure Figure 1Block diagram of analysis module 110B of mobile phone 110. As shown in some embodiments, analysis module 110B of mobile phone 110 includes data input interface 111, for interface or receiving data input from one or more activity monitors 130A, heart rate monitor 130B, glucose monitor 130C monitors outside or inside mobile phone 110 and in mobile phone 110. Data and / or information received via data input interface are provided to glucose response training unit 112. In some embodiments, glucose response training unit 112 classifies received input data into corresponding categories according to the type of data and the type or multiple types of parameters associated with the data. For example, if the data type is associated with a physical activity such as 90 minutes of running, then in addition to duration, the parameters associated with the data also include the level of running intensity (running, jogging, sprinting), which can be measured in some embodiments using monitored heart rate information (if available) or running stride (pace of run), aerobic or anaerobic running, competitive or non-competitive (training) running or any other suitable category (e.g., running) associated with physical activity. In certain embodiments, other types of data associated with physical activity may be used, such as the number of steps taken during an established time period.

[0042] Using the classification data received from one or more of the activity monitor 130A, the heart rate monitor 130B, the glucose monitor 130C ( Figure 1 ), retrieve (or from glucose monitor 130C ( Figure 1 ) receives) the time corresponding to the glucose level information, and the glucose response training unit 112 performs dynamic glucose response pattern recognition based on, for example, an analysis tool provided in the App for execution on the mobile phone 110. In addition, in some embodiments, the glucose response training unit 112 is configured to perform dynamic glucose response pattern recognition based on the information from one or more monitors ( Figure 1 )'s real-time information dynamically and continuously updates the measured glucose response pattern.

[0043] In certain embodiments, the accuracy of the glucose response pattern is improved with the increased data set in a longer time period (and / or with higher resolution / monitoring frequency). However, the glucose response of an individual to an input may change over time. Certain embodiments solve this problem by "resetting" or clearing the data set after a predetermined time period has passed. In other embodiments, the App identifies an error that may cause the accuracy of the glucose response pattern by exceeding the set data collection duration, in which case, when this time point has arrived, the App is configured to reset and enter the data collection period, during which the user-driven analysis of the glucose response feedback is disabled at least for the minimum number of days or hours required for the analysis and determination of the new glucose response pattern of the monitoring data. As described in further detail below, in certain embodiments, the App is configured to establish a "forget" window, during which the user-driven analysis of the glucose response feedback is continuously updated. In certain embodiments, the "forget" window includes one or more predetermined time periods set by the App or based on user input, or alternatively, dynamically modified based on the glucose response feedback.

[0044] Return to reference Figure 2A In certain embodiments, the output of the glucose response training unit 112 is provided to a data output interface 113, which is operably connected to a user interface 110A of the mobile phone 110 for displaying, outputting, or otherwise notifying or prompting a user of the mobile phone 110 that the App has completed an initial or preliminary analysis and is operable to analyze glucose responses to inputs, such as the number of steps taken, cycling, running, hiking, meals, etc., for which a user or patient expects to identify a corresponding glucose response, so as to take timely action (corrective or proactive) to maintain glucose control and minimize undesirable glucose fluctuations.

[0045] Figure 2A shows a combination according to one embodiment of the present disclosure Figure 1 The analysis module 110B performs data classification, pattern recognition and dynamic update of information flow. Figure 2A In some embodiments, the analysis module 110B ( Figure 1 , Figure 2A) is configured to classify (220) received input data (210), such as activity type, intensity level, duration, location, altitude information, glucose level, heart rate information, heart rate variability (HRV) information, oxygen saturation level, sweat level, temperature level, medication intake information, medication type, duration of medication administration, time of day information corresponding to medication administration, carbohydrate intake information, alcohol consumption information, or any other relevant metric for a particular monitoring condition corresponding to the received input data.

[0046] Using the received information, in certain embodiments, the glucose response training unit 112 ( Figure 2A ) performs dynamic glucose response pattern recognition and updates the pattern when new or additional data is received (220). As discussed in further detail below, in some embodiments, before outputting a glucose response curve (230) based on the determined pattern, the glucose response training unit 112 of the analysis module 110B in the mobile phone 110 ensures that sufficient input data has been analyzed. Once this point has been reached and the information monitored for at least a minimum duration has been received and analyzed, in some embodiments, the App is configured to generate a notification to the user (e.g., as an output prompt on the user interface 110A of the mobile phone 110) when it determines that the information may be useful to the user. The notification can be automatic, such as an alarm notification; or retrieved by the user when using the App, such as accessing the information from a menu; or displayed when the user next interacts with the App. An example of useful information is that the user's glucose level is typically 20% lower overnight after exercising during their previous day. The user can use this information to ensure that they do not experience low glucose at night, such as reducing their insulin coverage during this time, or by eating a snack before bed.

[0047] In another aspect of the present disclosure, the App prompts the user to enter contextual information when it detects certain situations that warrant the input of more information. The information entered is used by routines that analyze the input data to determine glucose response patterns. The App contains routines that detect situations, such as when eating or activity occurs, and notifies the user when these situations are detected. Embodiments of user notifications include one or more of an icon display, an auditory or text output notification, or a vibration notification, which is configured to prompt the user to provide more information about the detected situation. Examples of one or more situations include detected motion, a detected rate of change of glucose increase or decrease exceeding or accelerating beyond a set threshold, a detected spike or heart rate change, sweating, or temperature level. Alternatively, the App can provide a notification the next time the user interacts with the App or smartphone, rather than an alarm type notification.

[0048] Reference again Figure 2A In some embodiments, the glucose response training unit 112 of the analysis module 110B is configured to perform dynamic glucose response pattern recognition based on glucose metrics, which characterizes the impact of a specific activity or event for a specific user or patient, such as the impact of a specific activity or event (e.g., a meal or medication intake) occurring during and after the activity for a specific time of day period. Different glucose metrics such as average or median glucose levels can be used as glucose metrics. In some embodiments, using median glucose information is less susceptible to outlier glucose data than average glucose levels.

[0049] In certain embodiments, glucose response training unit 112 measures, for example, during the overnight time after a particular activity, such as from 10 p.m. to 3 a.m., or from 3 a.m. to 8 a.m., or from 10 p.m. to 8 a.m., the median of the glucose level of continuous monitoring. In certain embodiments, glucose response training unit 112 uses the median glucose level measured in daytime time period (for example, from 8 a.m. to 10 p.m., from 8 a.m. to 6 p.m., from 9 a.m. to 5 p.m., from 5 p.m. to 10 p.m. or any other suitable daytime time period scope). In certain embodiments, median glucose information is measured with reference to a particular activity, so that in a period of time after the activity starts (after 2 hours of the activity starts), a specific duration (for example, 12 hours) measures the median glucose level. In certain embodiments, the relative start time and the duration period for measuring the median glucose level change according to the type of activity and / or other parameters related to the activity or associated with a user or a patient.

[0050] Although the disclosed embodiments focus on activities during the daytime that affect glucose levels at night, within the scope of the present disclosure, similar analysis is applicable to any time period defined by a fixed time of the day, such as morning activities (e.g., 5 a.m. to 12 p.m.), affecting glucose levels after dinner (e.g., 6 p.m. to 10 p.m.). Alternatively, the analysis disclosed herein within the scope of the present disclosure is applicable to time periods defined by regularly occurring events. For example, an activity data set is generated from a time period defined as 5 a.m. to breakfast every day, wherein the breakfast time is different every day and is determined by an indication input or generated by a user, or by an algorithm that processes glucose data to determine the start of a meal or by a recorded rapid-acting insulin infusion. An exemplary embodiment of algorithmically detecting the start of a meal is disclosed in WO 2015 / 153482 (International Application No. PCT / US2015 / 023380 filed on March 30, 2015), which is assigned to the assignee of the present application, and its disclosure is incorporated herein by reference in its entirety for all purposes.

[0051] In addition, the affected time period can also be defined as a time period starting when a meal is detected, such as the start of dinner until midnight. Moreover, within the scope of the present disclosure, a hybrid method is provided, in which the activity time period is determined as a fixed day time period, and the affected time period is determined by a specific meal start time. Within the scope of the present disclosure, the impact on multiple time periods is included, such as after breakfast, after lunch, after dinner, and overnight. Moreover, the analysis can be extended to multiple days; for example, determining how activities occurring in the morning phase of the first day affect glucose levels on the subsequent day.

[0052] Furthermore, within the scope of the present disclosure, two or more activity types may be used for analysis. Non-limiting example requires a) the user enters the user interface (UI) of the App (e.g., the data input interface 111 ( Figure 2A )) contextual information about the activity they are performing, or b) using one or more sensors to distinguish between different types of activity, or c) alternative detection techniques for distinguishing between different types of activity. For the above user input information method (a), the App is configured to present a user interface (e.g., Figure 3As shown) to allow the user to enter activity information. In some embodiments, the user can enter information from a checklist or free text input. In addition, the App is configured to detect when the measured activity exceeds a predefined threshold and prompt the user to enter this information. For methods using one or more sensors to detect different activities (method (b)), a combination of a pedometer, a heart rate sensor, and a position sensor can be used, where one or more thresholds and defined logic are configured to identify body movement, intensity, speed, and altitude changes. Finally, for methods using alternative detection techniques (method (c)), for example, a position sensor can be used to detect when the user is in a weightlifting gym so that the measured activity can be associated with anaerobic activity.

[0053] When an activity type attribute is associated with a measured activity metric, the analysis described below can be performed for each activity type. For example, if two activity types are used, such as aerobic and anaerobic, the analysis described below can be used to determine the effect of aerobic activity on future glucose levels, and independently determine the effect of anaerobic activity on future glucose levels. Within the scope of the present disclosure, one or more combinations of activities and analysis time periods can be implemented, such as a day with two activity types indicating a new activity type.

[0054] In certain embodiments, the glucose response training unit 112 measures the median glucose level, activity, and other related parameters for multiple daytime time periods, and measures the median glucose level for the relevant overnight time period following the daytime time period. In certain embodiments, the glucose response training unit 112 measures the median glucose level for the daytime time period on days without activity. More specifically, in certain embodiments, the glucose response training unit 112 is configured to confirm with the user or patient that significant activity (e.g., exercise events, the number of steps taken within a daytime time period (12 hours, 18 hours, 24 hours or other suitable time period), running, bicycling, hiking, etc.) did not occur on those days without significant activity. Using the time periods separating those days with significant activity and those days without significant activity, in certain embodiments, the glucose response training unit 112 analyzes the received input data (see Figure 2A ) to characterize the effects of specific activities on overnight glucose levels to generate a dynamic glucose response pattern - that is, to evaluate how the user's or patient's body responds to a specific activity, and to generate or provide appropriate treatment recommendations to the user or patient when the user decides to participate in the same activity with the same or similar parameters such as duration, intensity level, etc.

[0055] Figure 3 is a data input interface 111 ( Figure 2A ). Reference Figure 3In some embodiments, a customized data entry screen is presented to the user for information entry for analysis by the App. In a non-limiting example, a set of radio buttons on a user interface (e.g., a user interface of a mobile phone executing the App) is seeded with one or more default activity-related parameters such as steps, running, jogging, hiking, biking, swimming, sleeping, and / or food / beverage-related parameters such as coffee, sugary alcohol, non-sugary alcohol, cereal, bacon, toast, etc., with options added by the user that change over time as new customized answers / feedback or responses are added. This allows the user to quickly enter the most common or most frequently used activity types without losing the flexibility of entering other types of custom data.

[0056] Within the scope of the present disclosure, the App provides a variety of means for users or patients to enter information about meals and activities. Patients can proactively enter this information. This is particularly suitable for meal input in which photos of meals can be entered. This may be a more convenient and interesting way for users or patients to enter and view meal information. Additional details can be found in the provisional patent application number ______ entitled "Systems, Devices, and Methods For Meal Information Collection, Meal Assessment, and Analyte Data Correlation" filed simultaneously with the present application [Agent File Number A0130.0134.P2]. As described above, in certain embodiments, the App can detect meals or activity episodes and prompt patients for more information, as disclosed in WO 2015 / 153482, which is incorporated herein by reference in its entirety for all purposes.

[0057] For users or patients who use insulin or take other glucose-altering medication, the App can be configured to automatically retrieve user / patient specific data regarding the use of these medications, or allow the patient to manually enter it into the system.

[0058] Within the scope of the present disclosure, App is configured to facilitate experimentation and understanding by providing meal / activity analysis output. In certain embodiments, the output is presented as one or more reports on a web browser on a smart phone or retrieved from a server. One or more reports list the meal situations defined by glucose excursion. The list of meal situations can be classified by the date-time of the situation or by the severity of the glucose excursion (e.g., measured by peak glucose level), by the glucose changes during the excursion process or by the area defined by glucose and excursion duration. Each row in the analysis output report includes information related to the meal situation. In certain embodiments, the report includes one or more photos or other text entries associated with the meal situation, date and time, and one or more meal severity metrics. In certain embodiments, the report also includes any relevant activity information within a period of time of the meal. Too much information on this list may be too messy and impractical. Therefore, in certain embodiments, App provides a presentation of manipulation information to a user or patient, such as selecting a row and presenting a pop-up window with a more detailed information screen. This detailed information screen also provides a glucose curve graph related to the meal situation. In this way, meals that have the greatest impact on glucose levels can be highlighted through an easy to view presentation to provide a better understanding of the impact of certain foods on their glucose levels so that the user or patient can avoid or limit foods that are not conducive to their health.

[0059] In certain embodiments, the App is also configured to learn how food and activity affect future glucose levels. When food and activity are selected on the above-mentioned customizable checklist, glucose data are associated with these selections, and multiple glucose data sets can be associated with a single entry type. Moreover, multiple glucose data sets can be associated with a combination of one or more meal entry types and one or more activity entry types. Glucose data sets can be processed in one or more different ways to characterize the impact of the situation on glucose levels.

[0060] In certain embodiments, the median glucose level from all data sets is measured and compared with the median of the time period of all captured glucose data. Alternatively, this method can be applied to a single day time period, such as before breakfast, after breakfast, after lunch, after dinner and after going to bed. Over time, App is configured to estimate the blood glucose impact for any given entry type or entry type combination with a certain degree of confidence. For example, a specific activity type "biking uphill" 1 hour or more hours of activity may be associated with a 20% increase in patient insulin sensitivity in the next 24 hours-the change in insulin resistance is easily associated with the change in median glucose. When the system detects that the statistical confidence level exceeds a certain predetermined amount, the system can make this association. This information may change the parameters used in the bolus calculator in the next 24 hours. Alternatively, App can detect activities related to cycling, and remind patients, for example, at bedtime, so that they can eat snacks that night to avoid hypoglycemia.

[0061] Another type of output report provided by the App includes a list of activities that can be sorted by median glucose levels within a time period (e.g., 24 hours) after the activity. The list can illustrate which activities have the greatest impact on future glucose levels. In addition, another type of report can present a list of food and activity combinations in the same manner as described. These methods can be easily extended to other sensor data and other contextual inputs, such as disease, alcohol consumption, coffee consumption, etc.

[0062] Figure 4 is a flow chart showing a routine for determining the effect of daytime activity on overnight glucose levels according to one embodiment of the present disclosure. Figure 4 In one embodiment, determining the effect of daytime activity on overnight glucose levels includes generating a metric to define overnight glucose levels for all days without significant activity within a predetermined time period (e.g., 2 weeks, a month, or any other suitable time period) (410). Thereafter, generating a metric to define overnight glucose levels for each day with significant activity within the predetermined time period (420). Within the scope of the present disclosure, determining days with or without significant activity is based on one or more activity metrics exceeding a defined threshold (e.g., the number of steps exceeding a threshold within a 24-hour time period). Return to Reference Figure 4After generating a metric to define the overnight glucose level for all days without significant activity, and a plurality of metrics to define the overnight glucose level for each day with significant activity, each of the plurality of metrics defining the overnight glucose level for each day with significant activity is modified using the metric for all days without significant activity (430). Then, a correlation is determined between each modified metric for days with significant activity and the metric for all days without significant activity (440), and thereafter, given an activity level, an effect on the overnight glucose level for the activity level is determined and presented to a user based on the determined correlation (450).

[0063] Figure 5 is a flow chart showing another routine for determining the effect of daytime activity on overnight glucose levels according to one embodiment of the present disclosure. Figure 5 In one embodiment, determining the effect of daytime activity on overnight glucose levels includes generating a metric to define the diurnal glucose level variation of all days without significant activity within a predetermined time period (e.g., 2 weeks, a month, or other suitable time period) (510). Thereafter, multiple metrics are generated to define the diurnal glucose level variation of each corresponding day with significant activity (520). For the metric of diurnal glucose level variation of each day with significant activity and the metric of diurnal glucose level variation of all days without significant activity, the metric of diurnal glucose level variation of the day without significant activity is used to modify the daily metric of diurnal glucose level variation of the day with significant activity (530). Then, the correlation relationship between each modified metric of the day with significant activity and the metric of all days without significant activity is determined (540). Using the determined correlation, for a given activity level, the effect of the activity level based on the determined correlation on the overnight glucose level is determined and presented to the user (550).

[0064] Figure 6 is a flow chart showing the identification and characterization of glucose response patterns for specific activities based on absolute overnight glucose levels according to one embodiment of the present disclosure. Figure 6 Based on input data received from one or more of the activity monitor 130A, the heart rate monitor 130B, and the glucose monitor 130C, the analysis module 110B ( Figure 2A ) of the glucose response training unit 112 determines whether the glucose response training unit 112 has been received through the data input interface 111 ( Figure 2A) receives a sufficient amount of data. In certain embodiments, the amount of data sufficient to perform the glucose response pattern and characterization analysis is based on data received within a predetermined number of days with significant activity and a predetermined number of days without significant activity (collectively referred to as "X"). In certain embodiments, whether a particular activity is suitable as a significant activity is determined based on one or more of the duration of the activity, the calories burned during the activity, the activity intensity level, whether the activity is an aerobic activity or an anaerobic activity, or the type of activity (e.g., a competitive activity or a non-competitive training activity). For example, in certain embodiments, the glucose response training unit 112 determines whether the glucose response pattern and characterization analysis is sufficient to perform the glucose response pattern and characterization analysis based on data received within a predetermined number of days with significant activity and a predetermined number of days without significant activity (collectively referred to as "X"). In certain embodiments, the glucose response training unit 112 determines whether the glucose response pattern and characterization analysis is suitable as a significant activity based on one or more of the duration of the activity, the calories burned during the activity, the activity intensity level, whether the activity is an aerobic activity or an anaerobic activity, or the type of activity (e.g., a competitive activity or a non-competitive training activity). Figure 1 )'s input data 1) 3 days with significant activity, and 3 days without significant activity provided a sufficient amount of data for analysis.

[0065] In alternative embodiments, the determination of data adequacy is based on the degree of certainty of the estimated glycemic pattern rather than a predetermined number of days or amount of data.

[0066] refer to Figure 6 , using the number of days of input data required for the determination analysis (610), the glucose response training unit 112 ( Figure 2A ) determines the median glucose level of all overnight median glucose levels for the determined days without significant activity (Gwo) (620). In certain embodiments, days without significant activity (Gwo) are defined as days during which the activity measurement is below a predefined threshold, such as 10,000 steps during a predetermined day time period (12 hours, 18 hours, or other suitable time period). In certain embodiments, the median glucose level of all overnight median glucose levels for days without significant activity (Gwo) varies according to the type of activity.

[0067] Afterwards, if Figure 6 As shown, for each day with significant activity (X days), a delta median glucose level (Gδ(X days)) is determined (630), where the delta median glucose level (Gδ(X days)) is the difference between the median overnight glucose level for a particular day G(X days) with significant activity and the median glucose level for all median overnight glucose levels for the measured days without significant activity (Gwo). That is:

[0068] (Gδ(X days)) = G(X days) - (Gwo)

[0069] In certain embodiments, the median glucose level (620) and the daily delta median glucose level (Gδ(X days)) (630) for all overnight median glucose levels for the measured days without significant activity (Gwo) are determined simultaneously. In other words, steps 620 and 630 can be performed in series, or in parallel with respect to each other.

[0070] Also refer to Figure 6 , determining a correlation relationship between the median glucose level (Gδ(X days)) of a day with significant activity (X days) and the activity metric (Act(X days)) of that day (640), and fitting the correlation to a predetermined function (650). In certain embodiments, the correlation relationship comprises a linear function, wherein the delta median glucose level of a day with significant activity (Gδ(X days)) is a linear function of the activity metric (Act(X days)). Within the scope of the present disclosure, the correlation relationship comprises a constant offset relationship, an exponential relationship, a logarithmic relationship, or a polynomial relationship between the delta median glucose level of a day with significant activity (Gδ(X days)) and the activity metric (Act(X days)).

[0071] In some embodiments, the activity metric (Act(X days)) is predetermined for a particular activity in which the user or patient is engaged and is based on, for example, glucose response training unit 112 ( Figure 2A ) performs input data classification 220 ( Figure 2B In some embodiments, the activity metric (Act(X days)) varies according to one or more parameters associated with the activity, including, for example, activity duration, intensity level, activity type, heart rate data associated with the activity, etc. In some embodiments, the activity metric (Act(X days)) includes a "step rate" such as steps per hour, or steps within a predetermined or fixed duration.

[0072] In certain embodiments, a least squares technique is applied to fit the correlation relationship to the data set. For example, the least squares method can be applied to the data set to determine the slope and offset of a linear relationship that defines the correlation between the delta median glucose level (Gδ(X days)) and the activity metric (Act(X days)) for days with significant activity. In certain embodiments, the linear relationship is then applied by the App to predict or anticipate the effect of significant exercise on overnight glucose levels. In other words, with a known or measured activity metric (Act(X days)), the App estimates the resulting delta median glucose level for days with significant activity by multiplying the activity metric (Act(X days)) by the slope of the linear correlation relationship and adding an offset (where the slope and offset are parameters determined, for example, by a best fit analysis). In certain embodiments, the best fit analysis is performed with the activity monitor 130A, the heart rate monitor 130B, the glucose monitor 130C ( Figure 1 ) is updated with each revision or addition to a data set collected or received. Alternatively, in certain embodiments, the best fit analysis is updated after a predetermined period of time of data set collection.

[0073] In certain embodiments, a set of ratios (R) measured for each day with significant activity is determined. These ratios are calculated as the delta median glucose level (Gδ(X days)) of the day with significant activity divided by the activity metric (Act(X days)). Then, the median or mean of the set of ratios is calculated. Then, the impact of the activity is determined by multiplying the median of the set of ratios (R) by the current activity metric (Act(X days)). Alternatively, within the scope of the present disclosure, a curve fitting method is applied, such as using a least squares technique to fit the set of ratios (R's) to a least squares fit line.

[0074] Return to reference Figure 6 In some embodiments, the number of days required for analysis (610) can be determined by the quality of the correlation (650). For example, in some embodiments, a linear line fit analysis provides a metric indicating the quality of such a line fit (e.g., a correlation coefficient R 2 Or the delta median glucose level on days with significant activity (standard error estimate of Gδ(X days)). In certain embodiments, if the line fit quality metric exceeds a certain value, such as (but not limited to), when the correlation coefficient R 2When the value is greater than 0.9 or the standard error of the delta median glucose level (Gδ(X days) for the days with significant activity for the linear fit is less than 10%, the data set is determined to be sufficient (610). If the linear fit is determined to be invalid, then in some embodiments, the App is configured to continue analyzing the data set (i.e., continue training), and each day linear fit is updated to determine whether it is valid. When the linear fit is determined to be valid, then in some embodiments, the analysis results are displayed, for example, on the data output interface 113 ( Figure 2A ) is presented to the user.

[0075] As a non-limiting example, Table 1 below shows a dataset collected for glucose response pattern recognition and characterization using the number of steps taken as an activity according to certain embodiments of the present disclosure.

[0076] Table 1. 14 days of active and inactive data

[0077]

[0078] From Table 1 above, it can be seen that within the two-week period, there were 6 days with activity (determined as the number of steps exceeding the threshold level - for example, 10,000 steps taken in 24 hours), including Day 1, Day 4, Day 5, Day 6, Day 9, and Day 13. It can also be seen that within the two-week period, there were 8 days without activity (determined as the number of steps below the threshold level (10,000 steps in 24 hours)), including Day 2, Day 3, Day 7, Day 8, Day 10, Day 11, and Day 12.

[0079] Given the daytime median glucose level for each of the 14 days and the corresponding overnight median glucose level for each of the 14 days, for days without significant activity (Gwo), the median glucose level of all overnight median glucose levels was determined by taking the median of the overnight median glucose levels for Days 2, 3, 7, 8, 10, 11, and 12 from Table 1, which was 143.5 mg / dL. In addition, for each day with activity (e.g., Day 1, 4, 5, 6, 9, and 13), the delta median glucose (Gdelta (X day)) was determined by subtracting the median glucose level of all overnight median glucose levels for days without significant activity (Gwo) determined to be 143.5 mg / dL from the corresponding overnight median glucose level (G(X day)). For example, for day 1 (activity), the delta median glucose (Gδ(day 1)) was 117 mg / dL minus 143.5 mg / dL (the median glucose level of all overnight median glucose levels for days without significant activity (Gwo)) resulting in a delta median glucose (Gδ(day 1)) of -26.5. Similarly, for day 4 (activity), the delta median glucose (Gδ(day 4)) was -18.5 (125 mg / dL minus 143.5 mg / dL). For day 5 (activity), the delta median glucose (Gδ(day 5)) was -32.5 (111 mg / dL minus 143.5 mg / dL). For day 6 (activity), the delta median glucose (Gδ(day 6)) was -23.5 (120 mg / dL minus 143.5 mg / dL). For day 9 (activity), the delta median glucose (Gδ(day 9)) was -12.5 (131 mg / dL minus 143.5 mg / dL). Finally, for day 13 (activity), the delta median glucose (Gδ(day 13)) was -38.5 (105 mg / dL minus 143.5 mg / dL).

[0080] Using the delta median glucose for each day with activity (Gδ(X days)) determined as described above, the corresponding R value for each day with activity (for the corresponding day with activity) is determined by dividing the determined delta median glucose (Gδ(X days)) by the activity measure (Act(X days)). For example, the R value for Day 1 is -0.002 (-26.5 divided by 12,503 steps (activity measure for Day 1). In this manner, R values ​​for days with activity are determined, and the resulting values ​​are shown in Table 2 below (with corresponding delta median glucose levels (Gδ(X days)).

[0081] Table 2

[0082]

[0083] Based on the data set determined as shown in Table 2 above, the days with activity relative to the corresponding R values ​​(such as Fig.11 Linear fitting analysis was performed on the

[0084] Alternatively, the median or mean R value can be used to represent the blood glucose pattern. In addition, a linear fit analysis can be performed on the delta median glucose (Gdelta(X days)) versus the activity level (number of steps), and as Fig.12 As shown:

[0085] It can be seen that the correlation coefficient R 2 is 0.9125, demonstrating an acceptable correlation, and where a linear fit analysis provides an offset of 10.811 with a slope of -0.0026. This line represents the blood glucose pattern.

[0086] use Fig.12 , when the user decides to perform a particular activity that will result in 15,000 steps, it can be seen from the linear fit analysis that such activity will result in a decrease in glucose levels of approximately 28 mg / dL. Using this information, if the user desires to maintain tighter glycemic control, and knows that performing 15,000 steps can reduce glucose levels by approximately 28 mg / dL, the user can take proactive actions to offset the effects of the activity (e.g., 15,000 steps), such as by consuming more food and / or beverages before or during participation in the activity.

[0087] In an alternative embodiment, the activity metric is converted into two values: significant activity or insignificant activity. In this case, the overnight glucose median level is associated with a day of significant activity or a day without significant activity, wherein significant activity is defined as when the activity measurement exceeds a predefined threshold (e.g., the day of the number of steps exceeding 10,000 steps). More specifically, with reference to Table 1, the median glucose of all overnight time periods associated with the day of significant activity is determined to be (day 1, day 4, day 5, day 6, day 9, and day 13) 118.5 mg / dL, and the median glucose level of all overnight time periods associated with insignificant activity (day 2, day 3, day 7, day 8, day 10, day 11, day 12, and day 14) is 143.5 mg / dL. The reduction in median activity is then determined by subtracting 143.5 mg / dL (as the median glucose level for all overnight time periods associated with non-significant activity) from 118.5 mg / dL (the median glucose for all overnight time periods associated with days of significant activity), which results in -25 mg / dL. The percent median reduction is then 17.42% (-25 mg / dL divided by 143.5 mg / dL). In this approach, whether a sufficient number of days for a data set have been collected can be determined by using a standard statistical test for determining whether the means of two different populations are different. For example, by confirming that the standard deviation of each median overnight glucose determination (with and without activity) is below a predetermined threshold, such as 20 mg / dL. Referring to Table 1, the standard deviation for days with significant activity (Day 1, Day 4, Day 5, Day 6, Day 9, and Day 13) was 8.864 mg / dL, while the standard deviation for days without significant activity (Day 2, Day 3, Day 7, Day 8, Day 10, Day 11, Day 12, and Day 14) was 7.08 mg / dL.

[0088] Reference again Figure 6 , using the glucose response pattern recognition and characterization described above, in certain embodiments, the App is configured to output to the user when subsequent significant activity is detected: "Overnight glucose levels tend to be 25 mg / dL lower for days with significant activity compared to days without significant activity." Alternatively, the result might be displayed as a percentage, for this example, 17% lower. The above techniques may be extended to any level of quantification, such as three or four levels, within the scope of the present disclosure.

[0089] In certain embodiments, the above routine is used in combination with Figure 6 , analysis module 110B ( Figure 2A) uses specific parameters to identify consistent glucose responses to specific activities. The user or patient then uses this information to modify or adjust the treatment regimen, meals consumed, or the type of activity performed given the underlying physiological state to maintain tight glycemic control and improve health.

[0090] Figure 7 is a flow chart showing the recognition and characterization of glucose response patterns for specific activities based on diurnal glucose level variations according to one embodiment of the present disclosure. Figure 7 , similar to Figure 5 In step 510, based on input data received from one or more of the activity monitor 130A, the heart rate monitor 130B, and the glucose monitor 130C, the analysis module 110B ( Figure 2A ) of the glucose response training unit 112 determines whether the glucose response training unit 112 has been received through the data input interface 111 ( Figure 2A ) receives a sufficient amount of data (710). Then, the glucose response training unit 112 of the analysis module 110B determines the median (Gwo(δ)) of all diurnal variations of the median glucose values ​​(Gd2n(X days)) for days without significant activity (determined as days that provide a sufficient amount of data) (720).

[0091] More specifically, each diurnal variation in median glucose without significant activity (Gd2n(Xday)) is determined by subtracting the median glucose level in a first predetermined daily time period (e.g., from 8am to 10pm) (Gday(Xday)) from the median glucose level in a second predetermined daily time period (e.g., from 10am to 6pm) (Gnight(Xday)) (720). That is:

[0092] (Gd2n(X days)) = G night (X days) - G day (X days)

[0093] In the scope of the present disclosure, the time period and the range of the first and second scheduled time periods of the day can be changed so that one is longer than the other, or alternatively, the two time periods are the same length. In certain embodiments, the first and second scheduled time periods of each day are measured based on specific events such as meal events or other indicators related to the patient.

[0094] Return to reference Figure 7, using the determined median of all diurnal variations of median glucose for days without significant activity (Gwo(δ))(720), in certain embodiments the glucose response training unit 112 determines a delta median glucose level (Gδ(X days))(730) by subtracting the median of all diurnal variations of median glucose for days without significant activity (Gwo(δ)) from the diurnal variation of median glucose for days without significant activity (Gd2n(X days)). In certain embodiments, the determination of the median of all diurnal variations of median glucose for days without significant activity (Gwo(δ))(720) and the determination of the delta median glucose level for each day with significant activity (Gδ(X days))(730) are determined simultaneously rather than sequentially. In alternative embodiments, the delta median glucose level (Gδ(X days)) for each day with significant activity (730) can be determined between the median of all diurnal variations of median glucose for days without significant activity (Gwo(δ))(720).

[0095] Thereafter, a correlation relationship between the median delta glucose (Gδ(X days)) and the activity measure (Act(X days)) for each day (X days) with significant activity (740) is determined. Figure 6 In some embodiments, the activity metric (Act(X days)) is predetermined for a particular activity in which the user or patient is engaged and thus may be based on the activity metric (Act(X days)) performed by the analysis module 110B. Figure 2A ) of the glucose response training unit 112 to perform input data classification ( Figure 2B ). Similarly, in some embodiments, the activity metric (Act(X days)) varies according to one or more parameters associated with the activity, including, for example, activity duration, intensity level, activity type, heart rate data associated with the activity.

[0096] Again, similar to combining Figure 6 Executed routines, see Figure 7 Once the correlation relationship between the delta median glucose level (Gδ(X day)) of a day with significant activity (X day) and the activity metric (Act(X day)) of that day is determined (740), the correlation relationship (e.g., in which the delta median glucose level (Gδ(X day)) of a day with significant activity is expressed as a linear function of the activity metric (Act(X day))) is used to generate an estimate of the delta median glucose level (Gδ(X day)) of a day with significant activity for the next overnight period of the day with significant activity, and the analysis results are displayed to the user. That is, the correlation is fitted to a predetermined function (750), and the resulting relationship is output to the user.

[0097] For example, with reference to the data set shown in Table 1, the median of all diurnal variations of the median glucose value for days without significant activity (Gwo (δ)) is -1.5. This is derived from the median of all diurnal variations of the median glucose value measured in the absence of significant activity (Gd2n (X days)). That is, as can be seen from Table 1, for each day without significant activity (day 2, day 3, day 7, day 8, day 10, day 11, day 12, and day 14), the median diurnal variation of the median glucose value (Gd2n (X days)) is measured by subtracting the daytime median glucose level from the overnight glucose level. For example, the median of the diurnal variation of the median glucose value on day 2 (Gd2n (day 2)) is -14 mg / dL (142 mg / dL-156 mg / dL). The median diurnal variation of the median glucose on day 3 (Gd2n (Day 3)) was 8 mg / dL (150 mg / dL-142 mg / dL). The median diurnal variation of the median glucose on day 7 (Gd2n (Day 7)) was 17 mg / dL (160 mg / dL-143 mg / dL). The median diurnal variation of the median glucose on day 8 (Gd2n (Day 8)) was 6 mg / dL (151 mg / dL-145 mg / dL). The median diurnal variation of the median glucose on day 10 (Gd2n (Day 10)) was 1 mg / dL (140 mg / dL-139 mg / dL). The median diurnal variation of the median glucose on day 11 (Gd2n (Day 11)) was -22 mg / dL (139 mg / dL-161 mg / dL). The median of the diurnal variation of the median glucose value on day 12 (Gd2n (Day 12)) was -11 mg / dL (144 mg / dL - 155 mg / dL). Finally, the median of the diurnal variation of the median glucose value on day 14 (Gd2n (Day 14)) was -4 mg / dL (143 mg / dL - 147 mg / dL). This is shown in Table 3 below.

[0098] Table 3

[0099]

[0100]

[0101] Where the median of all diurnal variations in median glucose for days without significant activity (Gwo(δ)) is determined to be -1.5, for each day with significant activity, the delta median glucose (Gδ(X days)) can be determined by subtracting the median of all diurnal variations in median glucose for days without significant activity (Gwo(δ)) from the median diurnal variation in median glucose for each day. This is shown in Table 4 below.

[0102] Table 4

[0103]

[0104] As can be seen in Table 4, for each day with significant activity, the corresponding R value was determined by dividing the determined delta median glucose (Gdelta(X days)) by the activity measure for the corresponding day with activity (Act(X days)).

[0105] In addition, in certain embodiments, rather than a linear function, a set of ratios (R) measured for each day with significant activity is generated. The ratio R is measured by dividing the median glucose (Gδ(X days)) of each day with significant activity by the corresponding activity metric (Act(X days)). Then, the median or mean value of the set of ratios R is measured (in this case, the median of the R values ​​for days with significant activity is -0.00199553198802936). Then, the effect of the activity can be measured by multiplying the median R by the current activity metric (Act(X days)). Alternatively, a curve fitting technique can be applied using, for example, the least squares method to fit the set of ratios (R's) into a line.

[0106] Fig.13 R values ​​plotted relative to days with activity are shown.

[0107] Alternatively, the median or mean R value can be used to represent the blood glucose pattern. In addition, the median δ glucose (Gδ(X days)) can be plotted against the activity metric (Act(X days)) and a linear fit analysis can be performed to obtain Fig.14 The curve shown.

[0108] according to Fig.14 The linear fit analysis shown, the correlation coefficient R 2 is about 0.86, the offset of the linear fit is 2.687, and the slope is -0.0022. Fig.14 As shown in the analysis, a user who wishes to participate in an activity that includes 15,000 steps can Fig.14 It is determined in the App that such activity will result in a decrease in glucose levels of approximately 30 mg / dL. Alternatively, the App includes a routine that estimates the upcoming overnight Gδ(X days) by inputting the day's activity into a linear equation. The user can then decide to take appropriate action (consume additional food / drinks during or before the activity) to better control the expected drop in glucose levels caused by the activity.

[0109] In an alternative embodiment, the activity metric (Act(X days)) can be classified into two values: significant activity or no significant activity. In this case, the overnight median glucose is associated with a day of significant activity or a day without significant activity, where significant activity is determined if the activity measurement exceeds a predefined threshold (e.g., greater than 10,000 steps for a one-day period). The median diurnal variation in median glucose levels for all overnight time periods associated with days with significant activity (Gd2n(X days)) is determined, as is the median diurnal variation in median glucose levels for all overnight time periods associated with no significant activity (Gd2n(X days)), and then the decline in median activity is determined. In certain embodiments, data adequacy is determined using statistical techniques; for example, by verifying that the standard error of each median calculation is below a predetermined threshold, such as 20 mg / dL.

[0110] For example, the median diurnal variation in median glucose levels for all overnight time periods associated with days with significant activity (Gd2n(X days)) was determined to be -28.5 mg / dL (taking the median of the diurnal variation in median glucose levels for days 1, 4, 5, 6, 9, and 13, which were -26, -25, -35, -31, -18, and -39, respectively), while the median diurnal variation in median glucose levels for all overnight time periods associated with no significant activity (Gd2n(X days)) was determined to be -1.5 mg / dL (taking the median of the diurnal variation in median glucose levels for days 2, 3, 7, 8, 10, 11, 12, and 14, which were -14, 8, 17, 6, 1, -22, -11, and -4, respectively). Thus, the median decrease in glucose levels could be determined to be -27 mg / dL (-1.5 mg / dL subtracted from -28.5 mg / dL).

[0111] In this case, when subsequent significant activity is detected as follows, the analysis results are displayed to the user by the App: "Glucose levels tend to be 27 mg / dL lower for days with significant activity compared to days without significant activity." Within the scope of the present disclosure, the analysis can be extended to any level of quantification, such as three or four levels.

[0112] Figure 8 is a flow chart showing the identification and characterization of glucose response patterns for specific activities based on the ratio of diurnal glucose levels according to one embodiment of the present disclosure. Figure 8 ,and Figure 8 Compared to the routine shown, the combination Figure 7 The analysis module 110B ( Figure 2A ) is that instead of using a routine with no significant activity (in Figure 7The median (Gwo(δ)) of all diurnal variations (Gd2n(X days)) of the median glucose level for the day of step 720, Figure 8 The routine in determines the number of days for which data is required for analysis (810), and then determines the median Gwod2nr of all diurnal ratios of the median glucose level (Gd2nr(X days)) of the days without significant activity (820). In certain embodiments, the diurnal ratio of the median glucose level (Gd2nr(X days)) of the days without significant activity is determined by dividing the median glucose level (Gnight(X days)) in a second predetermined time period of the day (e.g., from 10 pm to 6 am) by the median glucose level (Gday(X days)) in a first predetermined time period of the day (e.g., from 8 am to 10 pm). That is:

[0113] (Gd2nr(X days)) = G night (X days) / G day (X days)

[0114] Return to reference Figure 8 , the median (Gwo(δ)) of all diurnal ratios of the median glucose level (Gd2nr(X days)) of the days without significant activity is determined. Then, the glucose response training unit 112 of the analysis module 110B determines the delta median glucose (Gδ(X days)) for each day with significant activity by subtracting the median (Gwo(δ)) of all diurnal ratios of the median glucose level of the days without significant activity from the diurnal ratio (Gd2nr(X days)) of each day with significant activity (830). In certain embodiments, after determining the number of days of data required for analysis (810), the median (Gwo(δ)) of all diurnal ratios of the median glucose level (Gd2nr(X days)) of the days without significant activity (820) and the delta median glucose (Gδ(X days)) of each day with significant activity (830) are determined simultaneously rather than sequentially.

[0115] Reference again Figure 8 ,and Figure 7 Similar to step 740, a correlation relationship between the delta median glucose (Gδ(X days)) and the activity metric (Act(X days)) for each day is determined (840). This correlation relationship indicates a proportional decrease in the ratio of the diurnal glucose levels overnight after significant activity. The correlation between the delta median glucose (Gδ(X days)) and the activity metric (Act(X days)) for days with significant activity is fitted to a predetermined function (850), and the resulting correlation information is output to the user.

[0116] Referring again to the data set shown in Table 1 above, based on the median diurnal ratio of median glucose levels for days without significant activity as shown in Table 5 below, combined with Figure 8The described analysis resulted in a median Gwod2nr of 0.989991680125287 for all diurnal ratios of median glucose levels:

[0117] Table 5

[0118]

[0119] Then, as shown in Table 6 below, the ratio of the median level of glucose for each day with significant activity (Gactd2nr(X days)) can be determined by dividing the diurnal ratio of the median glucose level for each day with significant activity (Gactd2nr(X days)) by the median of each diurnal ratio of the median glucose level Gwod2nr (0.989991680125287).

[0120] Table 6

[0121]

[0122]

[0123] From Table 6, it can be determined that the median value of the median glucose ratio (Gactd2nr(X days)) for days with significant activity is 0.814595. Alternatively, the median glucose ratio (Gactd2nr(X days)) can be plotted relative to the activity measure (Act) for days with significant activity (e.g. Fig.15 Linear fitting analysis was performed.

[0124] It can be seen that Fig.15 The correlation coefficient R 2 is about 0.89, the offset is about 1.03, and the slope is -0.00002 (2E-05).

[0125] Fig. 9 A process flow for training and notification according to one embodiment of the present disclosure is shown. Fig. 9 In certain embodiments, for example, in combination with the above Figure 4-Figure 8 The described data analysis training is performed on the received input data set at predetermined time intervals (e.g., once a day). Each time the routine is executed, the new data set that has been acquired is added to the maintained data set and used for data analysis training, for example, to determine the correlation relationship between activity and future glucose levels (e.g., overnight glucose levels).

[0126] Return to reference Fig. 9In addition to adding new data sets to the training data set (910), each time the data analysis training routine is executed, older data (920), such as data that is 90 days or older or 180 days or older or any other suitable time period, is removed from the training set. This allows the data analysis training routine to adapt to the changing physiology ("forgetfulness") of the user from whom the data set was derived. In some embodiments, the "forgetfulness" subroutine may be excluded or optional. When a data analysis training process (930) has been included, in conjunction with Figure 4-Figure 8 The adequacy of training is checked as described above (940), such that, for example, an uncertainty measure associated with the "fit" of the correlation relationship is less than a predetermined threshold. If the training is determined to be sufficient (940), a notification of the result is generated and output (950). However, if the training is determined to be insufficient, no notification is generated or output. Alternatively, in some embodiments, when the App determines that the training is insufficient, a notification is not provided, but a notification indicating that the training is still insufficient may be provided.

[0127] Fig.10 FIG. 2 shows a process flow for training and notification according to another embodiment of the present disclosure. Fig.10 As shown, the data analysis training and notification routine is similar to Fig. 9 The routine shown and described in , where the "forgotten" feature is replaced by resetting (1010) or clearing (1020) the training data set. Fig.10 In some embodiments, the routine is reset (1010) and the training data set is cleared (1020) in response to actuation of an input button, such as on a user interface of the App, to reset the training routine. In some embodiments, the user initiates the reset (1010) of the routine and the clearing (1020) of the training data set in order to update the learned correlation relationship between activity and future glucose levels through the App.

[0128] refer to Fig.10 , when a reset is initiated, the data training and notification routines are invoked periodically thereafter, and are similar to Fig. 9 In the routine shown, a new data set is added to the training data set (1030), and after the training process is completed (1040), it is determined whether the training is sufficient (1050). When it is determined that the training is sufficient, in some embodiments the App generates and outputs a notification to the user (1060). When it is determined that the training is insufficient, no notification is presented to the user, or alternatively, a notification indicating insufficient training is generated by the App and presented to the user.

[0129] It is contemplated within the scope of this disclosure that the Fig. 9 and Fig.10Modifications to the dataset training and notification routine described herein, wherein the training dataset is reset (1010) / cleared (1020) Fig.10 ) features and "forgetting" features ( Fig. 9 ) are included in the same analysis routine. Moreover, in some embodiments, the reset occurs periodically, such as once a year. Alternatively, in some embodiments, the reset occurs after the training has provided effective notification (i.e., when it is determined that the training is sufficient).

[0130] In the manner described, according to embodiments of the present disclosure, tools are provided for patients with type 1 diabetes, type 2 diabetes, and prediabetes to monitor physiological conditions while participating in daily routines, and over time, an App that can be executed on a user's or patient's mobile phone, for example, provides a consistent glucose response to various types of activities and parameters that may affect glucose level fluctuations in the user or patient. Such a tool will allow the user or patient to modify diet, exercise routine, or other daily activities knowing how a specific diet, exercise, or activity affects glucose level fluctuations, and proactively take action to maintain desired blood sugar control and avoid harmful blood sugar excursions.

[0131] Embodiments of the present disclosure include aspects of data collection, including detecting specific activities and prompting a user or patient to input additional information related to the detected activities to make data collection more robust. For example, using activity monitor 130A, when an App executed on mobile phone 110 detects continuous motion for a predetermined period of time, in some embodiments, the App is configured to generate and output a query to user interface 110A to prompt the user or patient to confirm that the detected activity is occurring, and / or add additional information related to the detected activity (which may be generated and output to user interface 110A when termination of the activity is detected in some embodiments).

[0132] In this manner, according to embodiments of the present disclosure, a robust physiological parameter monitoring system and a dynamic glucose response mode are provided to provide consistent and reliable glucose responses to physiological or other parameters and activities.

[0133] Various other modifications and changes in the structures and methods of operation of the present disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the embodiments of the present disclosure. Although the present disclosure has been described in conjunction with specific embodiments, it should be understood that the disclosure claimed should not be unduly limited to such specific embodiments. It is intended that the appended claims define the scope of the present disclosure, and that structures and methods within the scope of these claims and their equivalents are thereby covered.

Claims

1. A method for identifying a glucose response pattern, comprising: receiving activity metric information and glucose level information over a predetermined time period, the predetermined time period comprising a plurality of days; categorizing overnight glucose level information for days within the predetermined time period that have significant activity measures as a first time period, and categorizing overnight glucose level information for days within the predetermined time period that do not have significant activity measures as a second time period; determining a median glucose G(X days) for all overnight glucose levels for the days within said first time period; determining a median glucose Gwo for all overnight glucose levels for the days within the second time period; determining a delta median glucose level Gδ(X days) for each day in the first time period by subtracting the median glucose Gwo from the median glucose G(X days); determining a correlation between the determined delta median glucose level for each day and the activity metric corresponding to the activity metric information for that day within the first time period; fitting the determined correlation to a predetermined function; and For a given activity level, the effect of activity level on overnight glucose levels was determined based on the determined correlation.

2. The method of claim 1, wherein days within the first time period include days having an activity metric exceeding a predetermined threshold, and further wherein days within the second time period include days having an activity metric below the predetermined threshold.

3. The method of claim 2, wherein the activity metric comprises an amount of calories burned during a 24-hour period.

4. The method of claim 2, wherein the activity metric comprises a number of steps recorded during a 24 hour period.

5. The method of claim 2, wherein the activity metric comprises one or more of: duration of the activity, intensity level of the activity, heart rate data associated with the activity, or type of activity. The method of claim 1 , wherein determining the correlation comprises identifying an association between each determined delta median glucose and a corresponding activity metric.

7. The method of claim 1, further comprising outputting information associated with the determined impact on a user interface.

8. The method of claim 7, wherein the output information includes blood glucose patterns.

9. The method of claim 1, wherein receiving glucose level information comprises generating a signal corresponding to the monitored glucose level with a glucose sensor.

10. The method of claim 9, wherein the glucose sensor generates a signal corresponding to the monitored glucose level from the dermal fluid.

11. The method of claim 9, wherein the glucose sensor generates a signal corresponding to the monitored glucose level from interstitial fluid.

12. The method of claim 9, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode comprising an analyte-responsive enzyme bound to a polymer disposed on the working electrode.

13. The method of claim 12, wherein the analyte-responsive enzyme is chemically bound to a polymer disposed on the working electrode.

14. The method of claim 12, wherein the working electrode comprises a mediator bound to a polymer disposed on the working electrode.

15. The method of claim 14, wherein the mediator is cross-linked to a polymer disposed on the working electrode.

16. The method of claim 9, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode, the working electrode comprising a mediator bound to a polymer disposed on the working electrode.

17. The method of claim 1, wherein the predetermined function comprises one of: a linear function, a constant offset relationship, an exponential relationship, a logarithmic relationship, or a polynomial relationship.

18. The method of claim 1, further comprising determining a number of days of data required for analysis based on the first time period and the second time period.

19. The method of claim 18, wherein determining the number of days of data required for the analysis comprises determining a quality of the correlation.

20. The method of claim 1, further comprising: A data analysis training routine is performed at a predetermined time period, the routine comprising: Add the new dataset to the training dataset; Conduct data analysis training process; Checking the adequacy of the training process; and A notification corresponding to the adequacy of the training process is generated and output.

21. The method of claim 20, further comprising removing data sets older than a predetermined period of time.

22. The method of claim 21, wherein the predetermined period of time is 90 days or more.

23. The method of claim 21, wherein the predetermined period of time is 180 days or more.

24. The method of claim 20, further comprising initiating a reset of the training routine and clearing the training data set.

25. The method of claim 20, wherein the predetermined period of time is once a day.

26. An apparatus for identifying a glucose response pattern, comprising: a data input module for receiving activity measurement information and glucose level information within a predetermined time period, the predetermined time period including a first time period and a second time period; A data analysis module is operably connected to the data input module and is configured to: categorizing overnight glucose level information for days within the predetermined time period having significant activity measures as a first time period, and categorizing overnight glucose level information for days within the predetermined time period not having significant activity measures as a second time period; determining a median glucose G(X days) for all overnight glucose levels for the days within said first time period; determining a median glucose Gwo for all overnight glucose levels for the days in the second time period; determining a delta median glucose level Gδ(X days) for each day in the first time period by subtracting the median glucose Gwo from the median glucose G(X days); determining a correlation between the determined delta median glucose level Gδ(X days) for each day and the activity metric corresponding to the activity metric information for that day within the first time period; fitting the determined correlation to a predetermined function; For a given activity level, the effect of activity level on overnight glucose levels was determined based on the determined correlation; and A data output interface is operably connected to the data analysis module to output information related to the determined impact.

27. The apparatus of claim 26, wherein days within the first time period include days having an activity metric exceeding a predetermined threshold, and further wherein days within the second time period include days having an activity metric below the predetermined threshold.

28. The apparatus of claim 27, wherein the activity metric comprises an amount of calories burned during a 24 hour period.

29. The apparatus of claim 27, wherein the activity metric comprises a number of steps recorded during a 24 hour period.

30. The apparatus of claim 27, wherein the activity metric comprises one or more of: duration of the activity, intensity level of the activity, heart rate data associated with the activity, or type of activity.

31. The apparatus of claim 26, wherein the plurality of days of data required for analysis is based on the activity metric information and glucose level information received during the predetermined time period.

32. The device of claim 26, wherein the output information includes blood glucose patterns.

33. The apparatus of claim 26, wherein the glucose level information is received from a glucose sensor positioned in contact with the bodily fluid to generate a signal corresponding to the glucose level information.

34. The device of claim 33, wherein the body fluid comprises dermal fluid.

35. The device of claim 33, wherein the body fluid comprises interstitial fluid.

36. The device of claim 33, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode comprising an analyte-responsive enzyme bound to a polymer disposed on the working electrode.

37. The device of claim 36, wherein the analyte-responsive enzyme is chemically bound to a polymer disposed on the working electrode.

38. The device of claim 36, wherein the working electrode comprises a mediator bound to a polymer disposed on the working electrode.

39. The device of claim 38, wherein the mediator is cross-linked to a polymer disposed on the working electrode.

40. The device of claim 33, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode, the working electrode comprising a mediator bound to a polymer disposed on the working electrode.

41. The device of claim 26, wherein the data output interface comprises a user interface of one or more of: a mobile phone, a tablet computing device, a server, a laptop computer, or a wearable device including a smart watch.

42. The apparatus of claim 26, wherein the predetermined function comprises one of: a linear function, a constant offset relationship, an exponential relationship, a logarithmic relationship, or a polynomial relationship.

43. The apparatus of claim 26, wherein the data analysis module is further configured to determine a number of days of data required for analysis based on the first time period and the second time period.

44. The apparatus of claim 43, wherein the data analysis module is configured to determine a number of days of data required for analysis to determine the quality of the correlation.

45. The apparatus of claim 26, wherein the data analysis module is further configured to: A data analysis training routine is performed at a predetermined time period, the routine comprising: Add the new dataset to the training dataset; Conduct data analysis training process; Check the adequacy of the training process; and A notification corresponding to the adequacy of the training process is generated and output.

46. ​​The apparatus of claim 45, wherein the data analysis module is further configured to remove data sets older than a predetermined period of time.

47. The apparatus of claim 46, wherein the predetermined period of time is 90 days or more.

48. The apparatus of claim 46, wherein the predetermined period of time is 180 days or more.

49. The apparatus of claim 45, wherein the data analysis module is further configured to initiate a reset of the training routine and clear the training data set.

50. The device of claim 45, wherein the predetermined period of time is once a day.

51. A method for identifying a relative change-based glucose response pattern, comprising: receiving activity metric information and glucose level information over a predetermined time period, the predetermined time period comprising a plurality of days; calculating a relative change in glucose level information between day and night for a plurality of days within the predetermined time period; classifying the relative change in glucose level information between day and night for days within the predetermined time period with significant activity measurement as a first time period, and classifying the relative change in glucose level information between day and night for days within the predetermined time period without significant activity measurement as a second time period; determining an activity metric for each day in the first time period from the activity metric information, and determining a glucose metric for the first time period from the glucose level information; determining an activity metric for each day in the second time period from the activity metric information, and determining a glucose metric in the second time period from the glucose level information; determining a median glucose of the glucose measurements determined during the first time period; determining a median glucose diurnal variation Gd2n(X days) of the determined glucose metric for the second time period by subtracting a median glucose level Gday(X days) for a first predetermined intraday period within the second time period from a median glucose level Gnight(X days) for a second predetermined intraday period within the second time period; Determine the median glucose Gwo(δ) of all median glucose diurnal variations Gd2n(X days) for the days in the second time period; determining a median glucose diurnal variation Gd2n(X days) of the glucose metric determined during the first time period by subtracting a median glucose level Gday(X days) during a first predetermined intraday period within the first time period from a median glucose level Gnight(X days) during a second predetermined intraday period within the first time period; Determining a delta median glucose level Gδ(X days) for each day in the first time period by taking the difference between the median glucose diurnal variation Gd2n(X days) in the first time period and the median glucose Gwo(δ) in the second time period; determining a correlation between the delta median glucose level Gδ(X days) determined for each day in the first time period and the activity metric corresponding to the activity metric information for that day in the first time period; fitting the determined correlation to a predetermined function; and For a given activity level, the effect of activity level on overnight glucose levels was determined based on the determined correlation.

52. The method of claim 51, wherein determining the glucose metric for the second time period comprises determining a relative change in glucose level information between day and night for each day within the second time period.

53. The method of claim 51, wherein determining the glucose metric during the second time period comprises determining a ratio between daytime glucose level information and nighttime glucose level information for each day during the second time period.

54. The method of claim 51, wherein days within the first time period include days having an activity metric exceeding a predetermined threshold, and further wherein days within the second time period include days having an activity metric below the predetermined threshold.

55. The method of claim 54, wherein the activity metric comprises an amount of calories burned during a 24 hour period.

56. The method of claim 54, wherein the activity metric comprises a number of steps recorded during a 24 hour period.

57. The method of claim 54, wherein the activity metric comprises one or more of: duration of the activity, intensity level of the activity, heart rate data associated with the activity, or type of activity.

58. The method of claim 51, wherein determining a correlation comprises identifying an association between each determined delta median glucose and a corresponding activity metric.

59. The method of claim 51 further comprising outputting information associated with the determined impact on a user interface.

60. The method of claim 59, wherein the output information includes blood glucose patterns.

61. The method of claim 51 , wherein receiving glucose level information comprises generating a signal corresponding to the monitored glucose level with a glucose sensor.

62. The method of claim 61, wherein the glucose sensor generates a signal corresponding to the monitored glucose level from the dermal fluid.

63. The method of claim 61, wherein the glucose sensor generates a signal corresponding to the monitored glucose level from interstitial fluid.

64. The method of claim 61, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode comprising an analyte-responsive enzyme bound to a polymer disposed on the working electrode.

65. The method of claim 64, wherein the analyte-responsive enzyme is chemically bound to a polymer disposed on the working electrode.

66. The method of claim 64, wherein the working electrode comprises a mediator bound to a polymer disposed on the working electrode.

67. The method of claim 66, wherein the mediator is cross-linked to a polymer disposed on the working electrode.

68. The method of claim 61, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode, the working electrode comprising a mediator bound to a polymer disposed on the working electrode.

69. The method of claim 51, wherein the predetermined function comprises a linear function.

70. The method of claim 51 , further comprising determining a number of days of data required for analysis based on the first time period and the second time period.

71. The method of claim 51 further comprising: A data analysis training routine is performed at a predetermined time period, the routine comprising: Add the new dataset to the training dataset; Conduct data analysis training process; Checking the adequacy of the training process; and A notification corresponding to the adequacy of the training process is generated and output.

72. The method of claim 71 further comprising removing data sets older than a predetermined period of time.

73. The method of claim 72, wherein the predetermined period of time is 90 days or more.

74. The method of claim 72, wherein the predetermined period of time is 180 days or more.

75. The method of claim 71 further comprising initiating a reset of the training routine and clearing the training data set.

76. The method of claim 71, wherein the predetermined period of time is once a day.

77. An apparatus for identifying a glucose response pattern, comprising: a data input module for receiving activity metric information and glucose level information for a predetermined time period, the predetermined time period comprising a plurality of days; A data analysis module is operably connected to the data input module and is configured to: calculating a relative change in glucose level information between day and night for a plurality of days within the predetermined time period; classifying the relative change in glucose level information between day and night for days within the predetermined time period having significant activity measures as a first time period, and classifying the relative change in glucose level information between day and night for days within the predetermined time period not having significant activity measures as a second time period; determining an activity metric for each day in the first time period from the activity metric information, and determining a glucose metric for the first time period from the glucose level information; determining an activity metric for each day in the second time period from the activity metric information, and determining a glucose metric in the second time period from the glucose level information; determining a median glucose of the glucose measurements determined during the first time period; determining a median glucose diurnal variation Gd2n(X days) of the determined glucose metric for the second time period by subtracting a median glucose level Gday(X days) for a first predetermined intraday period within the second time period from a median glucose level Gnight(X days) for a second predetermined intraday period within the second time period; Determine the median glucose Gwo(δ) of all median glucose diurnal variations Gd2n(X days) for the days in the second time period; determining a median glucose diurnal variation Gd2n(X days) of the glucose metric determined during the first time period by subtracting a median glucose level Gday(X days) during a first predetermined intraday period within the first time period from a median glucose level Gnight(X days) during a second predetermined intraday period within the first time period; Determining a delta median glucose level for each day of the first time period, Gδ(X days), by taking the difference between the median glucose diurnal variation Gd2n(X days) during the first time period and the median glucose Gwo(δ) during the second time period; determining a correlation between the delta median glucose level Gδ(X days) determined for each day in the first time period and the activity metric corresponding to the activity metric information for that day in the first time period; fitting the determined correlation to a predetermined function; For a given activity level, determining the effect of the activity level on overnight glucose levels based on the determined correlation; and a data output interface operably connected to the data analysis module to output information related to the determined effect.

78. The apparatus of claim 77, wherein the data analysis module is configured to determine the glucose metric during the second time period, and determine relative changes in glucose level information between day and night for each day during the second time period.

79. The apparatus of claim 77, wherein the data analysis module is configured to determine the glucose metric during the second time period, and to determine a ratio between daytime glucose level information and nighttime glucose level information for each day during the second time period.

80. The apparatus of claim 77, wherein days within the first time period include days having an activity metric exceeding a predetermined threshold, and further wherein days within the second time period include days having an activity metric below the predetermined threshold.

81. The apparatus of claim 80, wherein the activity metric comprises an amount of calories burned during a 24 hour period.

82. The apparatus of claim 80, wherein the activity metric comprises a number of steps recorded during a 24 hour period.

83. An apparatus according to claim 80, wherein the activity metric includes one or more of: duration of the activity, intensity level of the activity, heart rate data associated with the activity, or type of activity.

84. The apparatus of claim 77, wherein the data analysis module is configured to determine correlations identifying associations between each determined delta median glucose and a corresponding activity metric.

85. The device of claim 77, wherein the output information includes blood glucose patterns.

86. The apparatus of claim 77, wherein the glucose level information is received from a glucose sensor positioned in contact with the bodily fluid to generate a signal corresponding to the glucose level information.

87. The device of claim 86, wherein the body fluid comprises dermal fluid.

88. The device of claim 86, wherein the body fluid comprises interstitial fluid.

89. The device of claim 86, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode comprising an analyte-responsive enzyme bound to a polymer disposed on the working electrode.

90. The device of claim 89, wherein the analyte-responsive enzyme is chemically bound to a polymer disposed on the working electrode.

91. The device of claim 90, wherein the working electrode comprises a mediator bound to a polymer disposed on the working electrode.

92. The device of claim 91, wherein the mediator is cross-linked to a polymer disposed on the working electrode.

93. The device of claim 86, wherein the glucose sensor comprises a plurality of electrodes, the electrodes comprising a working electrode, the working electrode comprising a mediator bound to a polymer disposed on the working electrode.

94. The apparatus of claim 77, wherein the predetermined function comprises a linear function.

95. The apparatus of claim 77, wherein the data analysis module is further configured to determine a number of days of data required for analysis based on the first time period and the second time period.

96. The apparatus of claim 77, wherein the data analysis module is further configured to: A data analysis training routine is performed at a predetermined time period, the routine comprising: Add the new dataset to the training dataset; Conduct data analysis training process; Check the adequacy of the training process; and A notification corresponding to the adequacy of the training process is generated and output.

97. The apparatus of claim 77, wherein the data analysis module is further configured to remove data sets older than a predetermined period of time.

98. The apparatus of claim 77, wherein the predetermined period of time is 90 days or more.

99. The apparatus of claim 77, wherein the predetermined period of time is 180 days or more.

100. The apparatus of claim 77, wherein the data analysis module is further configured to initiate a reset of the training routine and clear the training data set.

101. The device of claim 77, wherein the predetermined period of time is once a day.

Citation Information

Patent Citations

  • Continuous glucose monitoring system and methods of use

    US20040186365A1

  • Method and system for providing data communication in continuous glucose monitoring and management system

    US20050182306A1

  • Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator

    US20060025662A1

  • In vitro analyte sensor, and methods

    US20070056858A1

  • In vitro analyte sensor and methods of use

    US20070068807A1